United Therapeutics (UTHR) Tops Q4 EPS Views
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $506.82 --0%
EPS Growth %: -10.1%
Financial Fact:
Cost of product sales: 23.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -10.1%
Financial Fact:
Cost of product sales: 23.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $3.68, $1.13 better than the analyst estimate of $2.55. Revenue for the quarter came in at $404.9 million versus the consensus estimate of $388.29 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler lists 5 chip stocks to buy
- American Eagle Outfitters (AEO) PT Lowered to $27 at UBS, Buy Rating Maintained
- Vince Holding (VNCE) Tops Q2 EPS by 86c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
